This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Antibody Engineering & Therapeutics Asia
19 - 21 October, 2026
The Westin Miyako KyotoKyoto, Japan

Troy Lionberger, PhD
Chief Business Officer at A-Alpha Bio, USA
Speaker

Profile

Troy Lionberger is the Chief Business Officer at A-Alpha Bio. Previously he was
Senior Manager of Technology Development at Berkeley Lights. Troy received his postdoctoral training in biophysics at U.C. Berkeley, prior to which he earned a Ph.D. in Cellular and Molecular Biology and Master’s in Mechanical Engineering from the University of Michigan.

Agenda Sessions

  • How millions of affinity measurements enable predictive multi-parameter antibody optimization in weeks.

    16:00